These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
86 related items for PubMed ID: 7459024
1. CEA and immunosuppression: investigation performed on patients with gastrointestinal advanced adenocarcinomas treated with immunochemotherapy. Mor C, Moro E, Accinni R, Bartorelli A, Secchi A, Orefice S. Boll Ist Sieroter Milan; 1980; 59(3):235-8. PubMed ID: 7459024 [Abstract] [Full Text] [Related]
4. Localization of carcinoembryonic antigen in mesenteric lymph nodes of patients with gastrointestinal cancer. Michalak T, Krawczyński K, Harłozińska A, Potomski J, Albert Z. Neoplasma; 1983; 30(1):67-72. PubMed ID: 6835439 [Abstract] [Full Text] [Related]
5. [Prognostic value of circulating immune complexes of carcinoembryonic antigen (CEA) in patients with adenocarcinoma of the gastrointestinal tract (author's transl)]. Staab HJ, Anderer FA, Stumpf E, Fischer R. J Clin Chem Clin Biochem; 1980 Mar; 18(3):175-81. PubMed ID: 7381371 [Abstract] [Full Text] [Related]
6. [Carcinoembryonic antigen (CEA). Clinical significance of postoperative concentration change of CEA in serums of patients with carcinoma of the stomach and intestinal tract]. Staab HJ, Kapsopoulou K, Anderer FA, Stumpt E, Fischer R. Med Welt; 1976 Apr 30; 27(18):864-7. PubMed ID: 1272048 [No Abstract] [Full Text] [Related]
7. Pilot study of a dual gene recombinant avipox vaccine containing both carcinoembryonic antigen (CEA) and B7.1 transgenes in patients with recurrent CEA-expressing adenocarcinomas. von Mehren M, Arlen P, Tsang KY, Rogatko A, Meropol N, Cooper HS, Davey M, McLaughlin S, Schlom J, Weiner LM. Clin Cancer Res; 2000 Jun 30; 6(6):2219-28. PubMed ID: 10873071 [Abstract] [Full Text] [Related]
15. Vaccine therapy of established tumors in the absence of autoimmunity. Hodge JW, Grosenbach DW, Aarts WM, Poole DJ, Schlom J. Clin Cancer Res; 2003 May 30; 9(5):1837-49. PubMed ID: 12738742 [Abstract] [Full Text] [Related]
16. Potential role of dendritic cell vaccination with MAGE peptides in gastrointestinal carcinomas. Tanaka F, Haraguchi N, Isikawa K, Inoue H, Mori M. Oncol Rep; 2008 Nov 30; 20(5):1111-6. PubMed ID: 18949409 [Abstract] [Full Text] [Related]
17. Tumour immunology and the gut. Calman KC. Gut; 1975 Jun 30; 16(6):490-9. PubMed ID: 50255 [Abstract] [Full Text] [Related]
18. Immunohistochemical detection of carcinoembryonic antigen in esophageal carcinomas: a comparison with other gastrointestinal neoplasms. Bhatnagar J, Heroman W, Murphy M, Austin GE. Anticancer Res; 2002 Jun 30; 22(3):1849-57. PubMed ID: 12168881 [Abstract] [Full Text] [Related]
19. Comparison of tumor M2-pyruvate kinase (tumor M2-PK), carcinoembryonic antigen (CEA), carbohydrate antigens CA 19-9 and CA 72-4 in the diagnosis of gastrointestinal cancer. Schneider J, Schulze G. Anticancer Res; 2003 Jun 30; 23(6D):5089-93. PubMed ID: 14981971 [Abstract] [Full Text] [Related]
20. Transcriptionally targeted in vivo gene therapy for carcinoembrionic antigen-producing adenocarcinoma. Konishi F, Maeda H, Yamanishi Y, Hiyama K, Ishioka S, Yamakido M. Hiroshima J Med Sci; 1999 Sep 30; 48(3):79-89. PubMed ID: 10598410 [Abstract] [Full Text] [Related] Page: [Next] [New Search]